(Q33792559)

29 July 2017

1 reference

title

Molecular pathogenesis of Bacillus anthracis infection (English)

1 reference

29 July 2017

0 references

Bacillus anthracis

1 reference

S F Little

1

1 reference

29 July 2017

B E Ivins

series ordinal

2

1 reference

29 July 2017

publication date

1 February 1999

1 reference

29 July 2017

published in

Microbes and Infection

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

131-139

1 reference

Anthrax vaccines: past, present and future

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Production in vitro of the toxin of Bacillus anthracis previously recognized in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Purification of factor I and recognition of a third factor of the anthrax toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Cloning and characterization of a gene whose product is a trans-activator of anthrax toxin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Crystal structure of the anthrax toxin protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Identification of residues lining the anthrax protective antigen channel

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Membrane insertion: The strategies of toxins (review).

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Location of receptor-binding region of protective antigen from Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Structural homology between virulence-associated bacterial adenylate cyclases

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Relationships between the calmodulin-dependent adenylate cyclases produced by Bacillus anthracis and Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Lethal factor active-site mutations affect catalytic activity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Zinc content of the Bacillus anthracis lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Role of macrophage oxidative burst in the action of anthrax lethal toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

The cytotoxic activity of Bacillus anthracis lethal factor is inhibited by leukotriene A4 hydrolase and metallopeptidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Interaction with a lipid membrane: a key step in bacterial toxins virulence.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Effect of Anthrax Toxin's Lethal Factor on Ion Channels Formed by the Protective Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthrax toxin protective antigen: low-pH-induced hydrophobicity and channel formation in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

The effects of pH on the interaction of anthrax toxin lethal and edema factors with phospholipid vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Secondary structure of anthrax lethal toxin proteins and their interaction with large unilamellar vesicles: a fourier-transform infrared spectroscopy approach

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Structure and interaction of PA63 and EF (edema toxin) of Bacillus anthracis with lipid membrane

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Characterization of macrophage sensitivity and resistance to anthrax lethal toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

On the role of macrophages in anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

THE ROLES OF SERUM AND CARBON DIOXIDE IN CAPSULE FORMATION BY BACILLUS ANTHRACIS

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Studies on infection with Bacillus anthracis; a histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Demonstration of a capsule plasmid in Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Identification of a novel gene, dep, associated with depolymerization of the capsular polymer in Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Identification and characterization of a trans-activator involved in the regulation of encapsulation by Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Plasmid-associated virulence factors of non-toxigenic (pX01−) Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Immunization studies with attenuated strains of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Human live anthrax vaccine in the former USSR.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Anthraxin skin testing: an alternative method for anthrax vaccine and post-vaccinal immunity assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Recent advances in the development of an improved, human anthrax vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Field Evaluation of a Human Anthrax Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

The effectiveness and safety of vaccines against human anthrax: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Construction of Bacillus anthracis mutant strains producing a single toxin component.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2980004-5

7 January 2021

10.1016/S1286-4579(99)80004-5

Identifiers

DOI

1 reference

29 July 2017

1 reference